Johnson & Johnson Soars on Positive Earnings and Outlook, Attracting Investor Interest

# J&J Stock Soars 2.61%: Wall Street Bullish Ahead of Q4 Earnings | Investment Analysis Discover why Johnson & Johnson (JNJ) shares jumped to $209.72 on January 12th with trading volume surging 47% above average. In this episode, we analyze Wall Street's optimistic outlook with a consensus "Buy" rating and price targets reaching as high as $240. Learn about J&J's impressive 45.81% one-year shareholder return, upcoming quarterly dividend of $1.30 per share (2.5% yield), and what to expect from their January 21st earnings report where analysts predict $2.52 EPS, up 23.53% year-over-year. Find out why this defensive healthcare giant with its $505 billion market cap and low volatility profile might be positioned for continued growth despite broader market uncertainties. #StockAnalysis #JohnsonAndJohnson #InvestmentStrategy #HealthcareStocks #DividendInvesting For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.